themarketforpetimagingreportcontents-bio-techsystems,inc.docVIP

themarketforpetimagingreportcontents-bio-techsystems,inc.doc

  1. 1、本文档共7页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  5. 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  6. 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  7. 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  8. 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
themarketforpetimagingreportcontents-bio-techsystems,inc

BIO-TECH SYSTEMS, INC. Market Research in the Health Care Field NEWS RELEASE 13900 Panay Way, R221 ((((((((((((((((( Marina Del Rey, California 90292 April 9, 2014 (424) 228-5793 (424) 228-5801 FAX E-Mail: mburns@ Web Site: ((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((( FOR IMMEDIATE RELEASE Contact: Marvin Burns Tel: (424) 228-5793 Fax:(424) 228-5801 BIO-TECH SYSTEMS ANNOUNCES THE RELEASE OF A NEW PET REPORT: Report 370: MARKET FOR PET RADIOPHARMACEUTICALS AND PET IMAGING ((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((—— GOOD PROSPECTS FOR PET RADIOPHARMACEUTICALS AND PET IMAGING, NEW PRODUCTS AND MARKETS FOR PET CARDIOLOGY, RAPID INTRODUCTION OF NEW ALZHEIMERS AGENTS, NEW PRODUCTS AND BIOMARKERS FOR ONCOLOGY, U.S AND WORLDWIDE MARKETS FOR PET SCANNERS, SALES FORECASTS TO 2021 Bio-Tech Systems Inc. announces the publication of a comprehensive report analyzing the markets for PET radiopharmaceuticals and PET imaging. This includes growth in cardiology, neurology and oncology. The report analyzes market opportunities as new products and biomarkers are introduced for imaging cardiac perfusion, myocardial viability and vulnerable plaque as well as congestive heart failure. Approval of new agents for imaging Alzheimers and other neurological diseases will also create new markets covering a broad class of neurological diseases involving dementia as well as Parkinsons disease. New oncology products are also emerging for apoptosis imaging, integrin biomarkers for angiogenesis and highly sensitive hypoxia imaging agents to optimize chemotherapy and radiotherapy. Demand for rubidium PET for cardiology is also increasing and will supplement new PET cardiology agents that should be approved shortly. The report also analyzes the U.S. and worldwide markets for PET scanners indicating the positive market response to the new PET-MR systems and expanded opportunities in time-of-flight imaging as well as increased choice for

文档评论(0)

2105194781 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档